You are here

TTR-FAP

Pfizer Announces Publication of New Analysis Showing Long-Term Therapy with VYNDAQEL (tafamidis) Slowed Progression of Rare Neurodegenerative Disease

Yahoo

Mon, 08/8/16 - 09:57 am

Pfizer's New Drug Failure Only Minor Setback

Motley Fool

Mon, 07/2/12 - 12:20 pm

tafamidis meglumine

Pfizer, FoldRx drug extends survival

Fierce Biotech

Wed, 04/13/11 - 10:52 am